Johnson & Johnson (NYSE: JNJ) EVP logs major option grants and stock sales
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Timothy Schmid, EVP and Worldwide Chair, MedTech at Johnson & Johnson, reported a series of equity award exercises, sales, and new grants. He sold 22,623 shares of Common Stock in open-market transactions around $244 per share on February 18, 2026 after exercising employee stock options.
Earlier in February, Schmid acquired shares through the vesting and conversion of Restricted Share Units and Performance Share Units, with some shares withheld to cover taxes as noted in the Long-Term Incentive Plan footnotes. On February 15, 2026, he received new grants of 35,489 employee stock options and 2,548 Restricted Share Units.
Following these transactions, Schmid directly held 26,769 shares of Common Stock, plus indirect holdings of 745 shares via a 401(k) and 46 shares via an ESOP as of the plans’ most recent reporting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 22,623 shares ($5,527,506)
Net Sell
22 txns
Insider
Schmid Timothy
Role
EVP, WW Chair, MedTech
Sold
22,623 shs ($5.53M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Options (Right to Buy) | 13,625 | $0.00 | -- |
| Exercise | Employee Stock Options (Right to Buy) | 8,998 | $0.00 | -- |
| Exercise | Common Stock | 13,625 | $115.67 | $1.58M |
| Sale | Common Stock | 13,625 | $244.20 | $3.33M |
| Exercise | Common Stock | 8,998 | $129.51 | $1.17M |
| Sale | Common Stock | 8,998 | $244.53 | $2.20M |
| Exercise | Restricted Share Units | 1,028 | $0.00 | -- |
| Exercise | Restricted Share Units | 1,026 | $0.00 | -- |
| Grant/Award | Employee Stock Options (Right to Buy) | 35,489 | $0.00 | -- |
| Grant/Award | Restricted Share Units | 2,548 | $0.00 | -- |
| Exercise | Common Stock | 1,028 | $0.00 | -- |
| Tax Withholding | Common Stock | 15 | $243.45 | $4K |
| Exercise | Common Stock | 1,026 | $0.00 | -- |
| Tax Withholding | Common Stock | 448 | $243.45 | $109K |
| Exercise | Restricted Share Units | 499 | $0.00 | -- |
| Exercise | Performance Share Units | 4,378 | $0.00 | -- |
| Exercise | Common Stock | 499 | $0.00 | -- |
| Tax Withholding | Common Stock | 8 | $244.55 | $2K |
| Exercise | Common Stock | 4,378 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,816 | $244.55 | $444K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Employee Stock Options (Right to Buy) — 0 shares (Direct);
Common Stock — 40,394 shares (Direct);
Restricted Share Units — 1,028 shares (Direct);
Performance Share Units — 0 shares (Direct);
Common Stock — 745 shares (Indirect, By 401k)
Footnotes (1)
- Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. Shares withheld for payment of taxes upon vesting of RSUs. Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. Shares withheld for payment of taxes upon vesting of PSUs. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. This transaction was executed in multiple trades at prices ranging from $244.20 to $244.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026). Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026). Each RSU represents a contingent right to receive one share of Company Common Stock. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.
FAQ
What did Johnson & Johnson (JNJ) executive Timothy Schmid report in this Form 4?
Timothy Schmid reported option exercises, equity award vesting, stock sales, and new grants. He exercised employee stock options, sold 22,623 Johnson & Johnson shares in the open market, and received additional stock options and restricted share units under the company’s Long-Term Incentive Plan.
What new equity awards did Timothy Schmid receive from Johnson & Johnson (JNJ)?
On February 15, 2026, Timothy Schmid received 35,489 employee stock options and 2,548 Restricted Share Units. These awards were granted under Johnson & Johnson’s Long-Term Incentive Plan and vest over time according to the plan’s multi-year installment schedules described in the footnotes.
What plans govern Timothy Schmid’s Johnson & Johnson equity awards?
Schmid’s options, RSUs, and PSUs were awarded under Johnson & Johnson’s Long-Term Incentive Plan. Footnotes explain that these awards generally vest in annual installments beginning one year after the grant date and convert into shares of Common Stock upon vesting on a one-for-one basis.